These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37394672)

  • 1. Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate.
    Montagna G; El-Tamer MB
    Ann Surg Oncol; 2023 Oct; 30(11):6290-6292. PubMed ID: 37394672
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
    Callcut RA; Breslin TM
    Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to "Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate.
    Munck F; Kroman NT; Tvedskov THF
    Ann Surg Oncol; 2024 Jan; 31(1):400. PubMed ID: 37932599
    [No Abstract]   [Full Text] [Related]  

  • 5. Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?
    van Zeeland M; Westhoff P; Wauters C; Bult P; Werner A; Laurens N; Strobbe L; Meijer H
    Breast J; 2020 Sep; 26(9):1869-1870. PubMed ID: 32524674
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding Axillary Management Pitfalls After Neoadjuvant Chemotherapy.
    Fan B; James T
    Ann Surg Oncol; 2022 Nov; 29(12):7265-7266. PubMed ID: 35972664
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer.
    Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR
    Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?
    Almahariq MF; Chen PY; Dekhne N; Dilworth JT
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):869-870. PubMed ID: 32737699
    [No Abstract]   [Full Text] [Related]  

  • 12. Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.
    Canavese G; Dozin B; Vecchio C; Tomei D; Villa G; Carli F; Del Mastro L; Levaggi A; Rossello C; Spinaci S; Bruzzi P; Catturich A
    Eur J Surg Oncol; 2011 Aug; 37(8):688-94. PubMed ID: 21696914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy in post-neoadjuvant chemotherapy breast cancer patients using preoperative breast tattooing-A novel technique.
    Bhargavan RV; Augustine P; Krishna JKM; Radhakrishnan N
    Breast J; 2021 Mar; 27(3):284-286. PubMed ID: 33506981
    [No Abstract]   [Full Text] [Related]  

  • 14. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
    Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
    Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sentinel node biopsy expands.
    Peres J
    J Natl Cancer Inst; 2013 Oct; 105(19):1423-4. PubMed ID: 24052620
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
    Piltin MA; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal Management of the Axilla: A Look at the Evidence.
    Mamounas ET
    Adv Surg; 2016 Sep; 50(1):29-40. PubMed ID: 27520860
    [No Abstract]   [Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
    Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H
    Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):848-849. PubMed ID: 32696307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.